ISSN: 1873-4294 (Online)
ISSN: 1568-0266 (Print)

Volume 18, 32 Issues, 2018

Current Topics in Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category

18^th of 59 in
Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA
USA

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Journal Home Editorial Policies Publishing Ethics Self-Archiving Policies Reviewer Guidelines Instructions for Authors Free Copies Online Contents & Abstracts Advertise With Us Library Recommendation Trial Requests Special Issue Submission Thematic Issues Open Access Funding

ISSN: 1873-4294 (Online)
ISSN: 1568-0266 (Print)
Volume 18, 32 Issues, 2018

Download PDF Flyer

Current Topics in Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category

18^th of 59 in
Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA
USA

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current Topics in Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category

18^th of 59 in
Chemistry, Medicinal

Submit Abstracts Online

Editor-in-Chief:
Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA
USA

View Full Editorial Board

Current Topics in Medicinal Chemistry, Volume 15 - Number 10

Editorial

Editorial (Thematic Issue: Recent Progress in Drug Discovery for Parkinson's Disease)

, 15(10): 905 - 907

Paul J. Gilligan

DOI: 10.2174/156802661510150328222828

View Editorial Permissions

Download Free

Dopamine D₃ Agonists in the Treatment of Parkinson's Disease

, 15(10): 908 - 926

Banibrata Das, Gyan Modi and Aloke Dutta

DOI: 10.2174/156802661510150328223428

View Abstract Permissions Order Reprints Order Eprints

View Abstract

Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson’s Disease

, 15(10): 927 - 938

Paul J. Gilligan

DOI: 10.2174/156802661510150328223655

View Abstract Permissions Order Reprints Order Eprints

View Abstract

Design and Development of a Novel Supportive Care Product for the Treatment of Sialorrhea in Parkinson’s Disease

, 15(10): 939 - 954

Neal M. Farber, Santiago Perez-Lloret and Elkan R. Gamzu

DOI: 10.2174/156802661510150328224130

View Abstract Permissions Order Reprints Order Eprints

View Abstract

Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease

, 15(10): 955 - 969

Juha Punnonen, James L. Miller, Timothy J. Collier and Jeffrey R. Spencer

DOI: 10.2174/156802661510150328224527

View Abstract Permissions Order Reprints Order Eprints

View Abstract

Current Topics in Medicinal Chemistry

Ranking and Category

Chemistry, Medicinal

Current Topics in Medicinal Chemistry

Ranking and Category

Chemistry, Medicinal

Current Topics in Medicinal Chemistry

Ranking and Category

Chemistry, Medicinal

Contents

Current Topics in Medicinal Chemistry, Volume 15 - Number 10

Editorial

Editorial (Thematic Issue: Recent Progress in Drug Discovery for Parkinson's Disease)

Paul J. Gilligan

Dopamine D3 Agonists in the Treatment of Parkinson's Disease

Banibrata Das, Gyan Modi and Aloke Dutta

Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson’s Disease

Paul J. Gilligan

Design and Development of a Novel Supportive Care Product for the Treatment of Sialorrhea in Parkinson’s Disease

Neal M. Farber, Santiago Perez-Lloret and Elkan R. Gamzu

Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease

Juha Punnonen, James L. Miller, Timothy J. Collier and Jeffrey R. Spencer

Dopamine D₃ Agonists in the Treatment of Parkinson's Disease